Bicocca Open Archive

Logo unimib boa
SCALONE, LUCIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.723
EU - Europa 2.629
AS - Asia 1.284
SA - Sud America 143
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 8.804
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.626
SG - Singapore 554
IT - Italia 470
DE - Germania 469
CN - Cina 369
SE - Svezia 359
RU - Federazione Russa 317
IE - Irlanda 297
UA - Ucraina 229
HK - Hong Kong 168
BR - Brasile 127
GB - Regno Unito 119
CA - Canada 93
AT - Austria 88
DK - Danimarca 77
FI - Finlandia 68
IN - India 47
FR - Francia 45
VN - Vietnam 35
TR - Turchia 30
NL - Olanda 27
BE - Belgio 21
ID - Indonesia 19
KR - Corea 13
IR - Iran 9
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
ES - Italia 7
CZ - Repubblica Ceca 6
JP - Giappone 6
TW - Taiwan 6
BG - Bulgaria 4
EU - Europa 4
KE - Kenya 4
PK - Pakistan 4
PL - Polonia 4
ZA - Sudafrica 4
AR - Argentina 3
AU - Australia 3
BD - Bangladesh 3
CL - Cile 3
EC - Ecuador 3
IQ - Iraq 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
CO - Colombia 2
JO - Giordania 2
MX - Messico 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
TH - Thailandia 2
A1 - Anonimo 1
BH - Bahrain 1
BO - Bolivia 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
HU - Ungheria 1
IL - Israele 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.804
Salva come PNG Salva come JPEG
Città #
Ann Arbor 700
Woodbridge 491
Chandler 368
Fairfield 344
Singapore 305
Houston 303
Frankfurt am Main 284
Dublin 282
Jacksonville 229
Wilmington 226
Ashburn 212
Dearborn 194
Hong Kong 167
New York 149
Seattle 140
Milan 132
Princeton 128
Santa Clara 128
Cambridge 116
Vienna 85
Nanjing 66
Altamura 57
Lawrence 54
Shanghai 53
Lachine 37
Fremont 33
Helsinki 27
Guangzhou 26
San Diego 26
Council Bluffs 23
Shenyang 23
Beijing 22
Andover 21
Tianjin 21
Moscow 20
Ottawa 19
Dong Ket 18
Toronto 18
Jakarta 17
Jinan 17
Brussels 16
Hebei 16
Nanchang 16
Jiaxing 15
Boston 13
Changsha 13
Los Angeles 13
London 11
Mountain View 11
Ningbo 10
Redmond 10
Rome 9
Zhengzhou 9
Bonndorf 8
Chicago 8
Falls Church 8
Hangzhou 8
Nürnberg 8
Angri 7
Huizen 7
Valencia 7
Boardman 6
Busto Arsizio 6
Edmonton 6
Manchester 6
Taipei 6
Taizhou 6
The Dalles 6
Dallas 5
Dubai 5
Indianapolis 5
Joliette 5
Kunming 5
Norwalk 5
Nuremberg 5
Nutley 5
Pune 5
São Paulo 5
Valmadrera 5
Belo Horizonte 4
Cattolica 4
Delhi 4
Hefei 4
Lissone 4
Nairobi 4
Nottingham 4
Rezzato 4
Seoul 4
Washington 4
Baghdad 3
Bergamo 3
Genoa 3
Hounslow 3
Kiev 3
Lanzhou 3
Legnano 3
Newtyle 3
Paris 3
Pistoia 3
Prague 3
Totale 5.974
Salva come PNG Salva come JPEG
Nome #
Administrative databases as a tool for identifying healthcare demand and costs in an over-one million population 355
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 313
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 257
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 211
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 207
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 202
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 202
Health Related Quality of Life in the Major Liver Conditions 194
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 193
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 192
Health related quality of life in chronic liver diseases 192
The impact of liver disease on the health-related quality of life 191
Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study 190
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 184
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 184
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 184
Sustainability of the Italian National Health Service 183
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases 180
Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting 180
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 178
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 177
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 170
Il burden delle polmoniti: analisi dai database amministrativi (DENALI) della regione Lombardia. 169
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 164
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 163
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 158
Immune tolerance induction in patients with haemophilia a and inhibitors: Effectiveness and cost analysis in an European Cohort (The ITER Study) 157
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 156
Utilization of disease modifying agents in multiple sclerosis: from an Italian administrative database. 150
Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases 147
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 146
Health related quality of life norm data of the general population in Italy: Results using the EQ-5D-3L and EQ-5D-5L instruments 143
Use of health care administrative databases to estimate the burden of breast cancer. 140
Italian population-based values of EQ-5D health states 136
Use of health care administrative databases to estimate incidence of foot complications in diabetes patients 133
Utilization of antispasticity drugs in multiple sclerosis: analysis from an Italian administrative database 133
Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases 131
Use of healthcare administrative databases to estimate the burden of diabaetes mellitus: a population-based study 130
Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: Results from Italy 128
Development of a segmentation model to identify healthcare demand and related costs attributable to population's characteristics 126
Use of health care administrative databases to estimate the burden of multiple sclerosis: a population-based study 123
Difference in health related quality of life of chronic liver diseases and general population 122
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 117
Analisi della domanda di salute attraverso l’impiego di database amministrativi regionali 112
Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study 109
Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens 109
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: The COCIS study group 106
Use of health care administrative databases to estimate the health care burden of bone or bone marrow metastatic disease in breast cancer patients: a population-based study. 105
Impatto dei trend demografici ed epidemiologici sulla sostenibilità del SSN. 100
Use of health care administrative databases to estimate the burden of diabetes mellitus: a population-based study 96
Use of health care administrative databases to estimate the health care burden of bone or bone marrow metastatic disease in breast cancer patients: a population-based study 96
Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids 90
The societal burden of chronic liver diseases: Results from the COME study 89
Patient Preferences and Willingness to Pay for different Options of Anticoagulant Therapy 86
Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study 77
Use of health-related quality-of-life measurements to estimate individuals' health on screening 74
Clinical use, quality of life and cost-effectiveness of spinal cord stimulation used to treat patients with failed back surgery syndrome 72
Obsessive compulsive tic disorder: Appropriate diagnosis and treatment as key elements to improve health and rationalize use of resources 71
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: A discrete choice experiment 69
Regarding "exploring patient involvement in decision making for vascular procedures" 69
Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: Results from the COHIBA Study 67
Preferences of patients, their family caregivers and vascular surgeons in the choice of abdominal aortic aneurysms treatment options: The PREFER study 63
Cost-effectiveness analysis of new drugs for chronic hepatitis C: The importance of updating utility values 59
Totale 9.210
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.041
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020220 0 0 0 0 0 0 0 0 0 97 96 27
2020/20211.076 97 76 153 101 91 72 91 76 95 86 71 67
2021/2022711 39 59 88 68 37 62 28 60 43 48 49 130
2022/20231.451 156 493 130 123 77 217 11 90 87 5 45 17
2023/2024890 32 30 26 49 98 258 168 20 81 11 10 107
2024/20251.534 131 221 124 96 205 101 155 54 291 156 0 0
Totale 9.210